Article summary
This qualitative study (n=4) explored former psychedelic-trial participants’ experiences of recruitment, preparation, dosing, integration and study ending. Participants said communication, staff relationships, uncertainty about treatment allocation, limited support and the end of trials shaped their experiences, and recommended clearer expectations, greater choice, continuity of care and structured peer support afterwards.
Continue to the original publication for the complete article.